• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1800067 重组全人源抗肿瘤坏死因子α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2018-06-14 神州细胞工程有限公司 SinoCelltech Ltd Certificate Issued 2018-10-15 view
CXSL1500089 重组全人源抗肿瘤坏死因子α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2015-11-19 神州细胞工程有限公司 SinoCelltech Ltd Certificate Issued 2017-05-22 view